Asian Journal Of Social Pharmacy

Objective To quantitatively analyze the policy of centralized drug procurement centralized drug procurement in order to provide reference for the subsequent policy formulation and improvement. Methods Text mining method was used to process 15 centralized drugs procurement policies issued at the national level during 2015-2022, and a PMC index evaluation model of centralized drug procurement policies was established. Then, 15 centralized drug procurement policies were quantitatively analyzed from the overall and comparative perspective through an evaluation model. Results and Conclusion The average PMC index of 15 centralized drug procurement policies was 6.95, which was acceptable on the whole. Among them, eight were excellent and seven were acceptable. As to the first-order variables, the centralized drugs procurement policy still lacks incentives and constraints. The comparative results show that there are differences in the content and structure of policies, but they are strongly related to each other. Chinese centralized drug procurement policy has been basically formed, which is closely related to medical insurance and medical policies. However, it is still necessary to pay attention to the structure of the policy to ensure the elaboration of the policy content.